4000-520-616
欢迎来到免疫在线!(蚂蚁淘生物旗下平台)  请登录 |  免费注册 |  询价篮
主营:原厂直采,平行进口,授权代理(蚂蚁淘为您服务)
咨询热线电话
4000-520-616
当前位置: 首页 > 产品中心 > juhewu > Sino Biological/uPAR/PLAUR cDNA ORF Clone in Cloning Vector, Mouse/1/MG50160-M
商品详细Sino Biological/uPAR/PLAUR cDNA ORF Clone in Cloning Vector, Mouse/1/MG50160-M
Sino Biological/uPAR/PLAUR cDNA ORF Clone in Cloning Vector, Mouse/1/MG50160-M
Sino Biological/uPAR/PLAUR cDNA ORF Clone in Cloning Vector, Mouse/1/MG50160-M
商品编号: MG50160-M
品牌: sinobiological
市场价: ¥0.00
美元价: 0.00
产地: 美国(厂家直采)
公司:
产品分类: 聚合物
公司分类: juhewu
联系Q Q: 3392242852
电话号码: 4000-520-616
电子邮箱: info@ebiomall.com
商品介绍

uPAR/PLAUR cDNA ORF Clone in Cloning Vector, Mouse: General Information

Gene
Species
Mouse
NCBI Ref Seq
NM_011113.3
RefSeq ORF Size
984 bp
Sequence Description
Identical with the Gene Bank Ref. ID sequence.
Description
Full length Clone DNA of Mouse plasminogen activator, urokinase receptor.
Plasmid
Vector
pMD18-T Simple Vector
Sequencing Primers
M13-47 and RV-M
Quality Control
The plasmid is confirmed by full-length sequencing.
Screening
Antibiotic in E.coli
Ampicillin
Storage & Shipping
Shipping
Each tube contains lyophilized plasmid.
Storage
The lyophilized plasmid can be stored at ambient temperature for three months.

uPAR/PLAUR cDNA ORF Neucleotide Sequence and Amino Acid Sequence Information

**Sino Biological guarantees 100% sequence accuracy of all synthetic DNA constructs we deliver, but we do not guarantee protein expression in your experimental system. Protein expression is influenced by many factors that may vary between experiments or laboratories.**

uPAR/PLAUR cDNA ORF Clone in Cloning Vector, Mouse: Synonyms

Cd87 cDNA ORF Clone, Mouse; u-PAR cDNA ORF Clone, Mouse; uPAR cDNA ORF Clone, Mouse

uPAR/PLAUR Background Information

Urokinase plasminogen activator (uPA) and/or its receptor (uPAR) are essential for metastasis, and overexpression of these molecules is strongly correlated with poor prognosis in a variety of malignant tumours. uPAR and uPA levels in both resected tumor tissue and plasma are of independent prognostic significance for patient survival in several types of human cancer. This system has classically been thought to drive tumor progression by mediating directed extracellular proteolysis on the surface of migrating or invading cells, and intervening with this proteolysis by targeting uPAR has been proposed to represent a novel approach for inhibiting tumor progression. uPAR, also known as PLAUR or CD87, has been implicated in the growth, metastasis, and angiogenesis of several solid and hemotologic malignancies. uPAR is a highly glycosylated, 55-60kDa integral membrane protein linked to the plasma membrane by a glycosylphosphatidylinositol (GPI) anchor. It is part of a cell surface system that also consists of the serine protease uPA and several specific inhibitors (plasminogen activator inhibitors 1 and 2). Additionally, the analysis of CD87 (urokinase-type plasminogen activator receptor - uPAR) expression has a potential role in the diagnostic or prognostic work-up of several hematological malignancies, particularly acute leukemia and multiple myeloma.
Full Name
plasminogen activator, urokinase receptor
Research Areas
  • Serine Proteases and Regulators
References
  • Romer J, et al. (2004) The urokinase receptor as a potential target in cancer therapy. Curr Pharm Des. 10(19): 2359-76.
  • Bn MC, et al. (2004) CD87 (urokinase-type plasminogen activator receptor), function and pathology in hematological disorders: a review. Leukemia. 18(3): 394-400.
  • Pillay V, et al. (2007) The urokinase plasminogen activator receptor as a gene therapy target for cancer. Trends Biotechnol. 25(1): 33-9.
  • Mazar AP. (2008) Urokinase plasminogen activator receptor choreographs multiple ligand interactions: implications for tumor progression and therapy. Clin Cancer Res. 14(18): 5649-55.

uPAR/PLAUR cDNA ORF Clone, Human,Related Products

  • uPAR/PLAUR cDNA ORF Clone, Human, C-His tagHG10925-CH
  • uPAR/PLAUR cDNA ORF Clone, Human, C-HA tagHG10925-CY
  • uPAR/PLAUR cDNA ORF Clone, Human, C-OFPSpark® tagHG10925-ACR
  • uPAR/PLAUR cDNA ORF Clone, Human, C-DYKDDDDK (Flag®) tagHG10925-CF
  • uPAR/PLAUR cDNA ORF Clone, Human, N-Myc tagHG10925-NM
  • uPAR/PLAUR cDNA ORF Clone, Human, N-DYKDDDDK (Flag®) tagHG10925-NF
  • uPAR/PLAUR cDNA ORF Clone, Human, C-Myc tagHG10925-CM
  • uPAR/PLAUR cDNA ORF Clone in Cloning Vector, HumanHG10925-M
  • uPAR/PLAUR cDNA ORF Clone, Human, N-His tagHG10925-NH
  • uPAR/PLAUR cDNA ORF Clone, Human, C-GFPSpark® tagHG10925-ACG
  • uPAR/PLAUR cDNA ORF Clone, Human, N-HA tagHG10925-NY
  • uPAR/PLAUR cDNA ORF Clone, Human, untaggedHG10925-UT
  • uPAR/PLAUR Lentiviral cDNA ORF Clone, Human, C-GFPSpark® tagHG10925-ACGLN
  • Human uPAR/PLAUR qPCR Primer PairHP100807

uPAR/PLAUR cDNA ORF Clone, Mouse,Related Products

  • uPAR/PLAUR cDNA ORF Clone, Mouse, C-GFPSpark® tagMG50160-ACG
  • uPAR/PLAUR cDNA ORF Clone, Mouse, N-Myc tagMG50160-NM
  • uPAR/PLAUR cDNA ORF Clone, Mouse, C-Myc tagMG50160-CM
  • uPAR/PLAUR cDNA ORF Clone, Mouse, C-HA tagMG50160-CY
  • uPAR/PLAUR cDNA ORF Clone, Mouse, C-DYKDDDDK (Flag®) tagMG50160-CF
  • uPAR/PLAUR cDNA ORF Clone, Mouse, C-OFPSpark® tagMG50160-ACR
  • uPAR/PLAUR Lentiviral cDNA ORF Clone, Mouse, C-GFPSpark® tagMG50160-ACGLN
  • uPAR/PLAUR cDNA ORF Clone, Mouse, N-DYKDDDDK (Flag®) tagMG50160-NF
  • uPAR/PLAUR cDNA ORF Clone, Mouse, N-HA tagMG50160-NY
  • uPAR/PLAUR cDNA ORF Clone, Mouse, C-His tagMG50160-CH
  • uPAR/PLAUR cDNA ORF Clone, Mouse, N-His tagMG50160-NH
  • uPAR/PLAUR cDNA ORF Clone, Mouse, untaggedMG50160-UT
  • Mouse uPAR/PLAUR qPCR Primer PairMP200190
  • A reassessment of soluble urokinase-type plasminogen activator receptor in glomerular disease
    Author
    Spinale, JM;Mariani, LH;Kapoor, S;Zhang, J;Weyant, R;Song, PX;Wong, HN;Troost, JP;Gadegbeku, CA;Gipson, DS;Kretzler, M;Nihalani, D;Holzman, LB;
    Year
    2014
    Journal
    Kidney Int.
    Application
    expression
    PubMed ID: 25354239FoldedExpand

If you couldn"t find the specific citation, you can:

  • Find All Citations
  • Submit a CitationGet a Publication Reward
  • Leave Us a Message
品牌介绍
北京义翘神州科技股份有限公司(Sino Biological Inc.)是一家从事生物试剂研发、生产、销售并提供技术服务的生物科技公司,主要业务包括重组蛋白、抗体、基因和培养基等产品,以及重组蛋白、抗体的开发和生物分析检测等服务。义翘神州为全球的药品研发企业和生命科学研究机构提供高质量的生物试剂产品和高水平的技术服务。公司目前生产和销售的现货产品种类超过 4.6 万种,其中重组蛋白约 6,000 种,包括超过 3,800 种人源细胞表达重组蛋白产品,能够全面满足客户对于最接近人体天然蛋白结构和性质的重组蛋白需求;公司还能提供约 12,000 种抗体,其中单克隆抗体数量约 4,600 种,能够覆盖生命科学研究的多个领域,为分子生物学、细胞生物学、免疫学、发育生物学、干细胞研究等基础科研方向和创新药物研发提供「一站式」生物试剂产品和技术服务。义翘神州的客户涵盖大学、科研院所、医药研发企业等国内外各类生物研发单位。目前公司已经在美国、欧洲建立了子公司,已成为生物试剂行业国内领先的科技公司之一。